Michael Gelband’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Michael Gelband's ATRC Position: Q2 2026 in Review
Michael Gelband opened a new position in AtriCure (ATRC) in Q2 2026: 86,356 shares worth $2.42M. The stake represents 0.02% of the portfolio and ranks #755 among its holdings. This is a return to the name: Michael Gelband previously reported a position in ATRC as recently as Q4 2025.
Michael Gelband first reported a position in ATRC in Q1 2020 and has held it in 16 quarters since. The position peaked at $10.5M in Q4 2021. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Michael Gelband held 86,356 shares of AtriCure worth $2.42M as of Q2 2026.
- AtriCure was a new Michael Gelband position in Q2 2026.
- AtriCure made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #755 holding.
- Michael Gelband first reported a position in AtriCure in Q1 2020 and has held it in 16 quarters since.
- Michael Gelband's AtriCure position peaked at $10.5M in Q4 2021.
- 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.